Stan V. Smith - 16 Feb 2023 Form 4 Insider Report for MAIA Biotechnology, Inc. (MAIA)

Role
Director
Signature
/s/ Stan V. Smith
Issuer symbol
MAIA
Transactions as of
16 Feb 2023
Net transactions value
+$582
Form type
4
Filing time
21 Feb 2023, 05:58:15 UTC
Previous filing
16 Feb 2023
Next filing
23 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MAIA Common Stock Purchase $264 +62 +0.01% $4.25 514,171 16 Feb 2023 See Footnote F1
transaction MAIA Common Stock Purchase $319 +75 +0.01% $4.25 514,246 17 Feb 2023 See Footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.